DNUT KRISPY KREME INC revenue, earnings and financials

For the quarter ended June 28, 2026, KRISPY KREME INC reported revenue of $331M (down 12.8% from a year earlier), net income of −$20.3M and diluted EPS of −$0.12; over the last four quarters revenue was $1.47B and net income −$98.3M; for the fiscal year ended December 2025 revenue was $1.52B, down 8.6% on the year before.

DNUT annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $1.52B, gross profit n/a, operating income −$469M, net income −$524M (margin -34.4%), EPS −$3.04
• Fiscal year ended Dec 2024: revenue $1.67B, gross profit n/a, operating income −$8.74M, net income $3.82M (margin 0.2%), EPS $0.02
• Fiscal year ended Dec 2023: revenue $1.69B, gross profit n/a, operating income $13.1M, net income −$36.6M (margin -2.2%), EPS −$0.23
• Fiscal year ended Jan 2023: revenue $1.53B, gross profit n/a, operating income $29.0M, net income −$8.78M (margin -0.6%), EPS −$0.10
• Fiscal year ended Jan 2022: revenue $1.38B, gross profit n/a, operating income $41.1M, net income −$14.8M (margin -1.1%), EPS −$0.18

DNUT quarterly revenue and earnings

• Quarter ended Jun 28, 2026: revenue $331M (down 12.8% year over year), net income −$20.3M, EPS −$0.12
• Quarter ended Mar 29, 2026: revenue $367M (down 2.2% year over year), net income −$22.8M, EPS −$0.16
• Quarter ended Dec 28, 2025 (from the annual report): revenue $392M (down 2.9% year over year), net income −$35.8M, EPS −$0.16
• Quarter ended Sep 28, 2025: revenue $375M (down 1.2% year over year), net income −$19.4M, EPS −$0.11
• Quarter ended Jun 29, 2025: revenue $380M (down 13.5% year over year), net income −$435M, EPS −$2.55
• Quarter ended Mar 30, 2025: revenue $375M (down 15.3% year over year), net income −$33.3M, EPS −$0.22
• Quarter ended Dec 29, 2024 (from the annual report): revenue $404M (down 10.4% year over year), net income −$21.7M, EPS −$0.13
• Quarter ended Sep 29, 2024: revenue $380M (down 6.8% year over year), net income $39.6M, EPS $0.23
• Quarter ended Jun 30, 2024: revenue $439M (up 7.3% year over year), net income −$5.49M, EPS −$0.03
• Quarter ended Mar 31, 2024: revenue $443M (up 5.7% year over year), net income −$8.53M, EPS −$0.05
• Quarter ended Dec 31, 2023 (from the annual report): revenue $451M (up 11.4% year over year), net income $3.89M, EPS $0.01
• Quarter ended Oct 1, 2023: revenue $407M (up 7.9% year over year), net income −$40.5M, EPS −$0.24
• Quarter ended Jul 2, 2023: revenue $409M (up 9.0% year over year), net income $223K, EPS $0.00
• Quarter ended Apr 2, 2023: revenue $419M (up 12.5% year over year), net income −$301K, EPS $0.00
• Quarter ended Jan 1, 2023 (from the annual report): revenue $405M (up 9.2% year over year), net income $4.13M, EPS −$0.02
• Quarter ended Oct 2, 2022: revenue $378M (up 10.1% year over year), net income −$13.1M, EPS −$0.08
• Quarter ended Jul 3, 2022: revenue $375M (up 7.5% year over year), net income −$3.85M, EPS −$0.02
• Quarter ended Apr 3, 2022: revenue $373M (up 15.8% year over year), net income $4.00M, EPS $0.02
• Quarter ended Jan 2, 2022 (from the annual report): revenue $371M, net income $11.0M, EPS $0.02
• Quarter ended Oct 3, 2021: revenue $343M, net income −$5.66M, EPS −$0.04

DNUT cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $33.9M, share buybacks $1.35M, dividends $0.04 per share
• Fiscal year ended Dec 2024: operating cash flow $45.8M, share buybacks $5.49M, dividends $0.04 per share
• Fiscal year ended Dec 2023: operating cash flow $45.5M, share buybacks $1.88M, dividends $0.04 per share
• Fiscal year ended Jan 2023: operating cash flow $140M, share buybacks $4.02M, dividends $0.04 per share
• Fiscal year ended Jan 2022: operating cash flow $141M, share buybacks $139M, dividends $0.04 per share

DNUT balance sheet

• Jun 28, 2026: cash $21.8M, total assets $2.36B, total liabilities $1.74B, shareholders' equity $618M, long-term debt $794M
• Mar 29, 2026: cash $74.2M, total assets $2.39B, total liabilities $1.75B, shareholders' equity $632M, long-term debt $830M
• Dec 28, 2025: cash $42.4M, total assets $2.59B, total liabilities $1.92B, shareholders' equity $650M, long-term debt $912M
• Sep 28, 2025: cash $30.7M, total assets $2.60B, total liabilities $1.91B, shareholders' equity $670M, long-term debt $906M
• Jun 29, 2025: cash $21.3M, total assets $2.63B, total liabilities $1.91B, shareholders' equity $694M, long-term debt $889M
• Mar 30, 2025: cash $18.7M, total assets $3.09B, total liabilities $1.96B, shareholders' equity $1.10B, long-term debt $935M
• Dec 29, 2024: cash $29.0M, total assets $3.07B, total liabilities $1.91B, shareholders' equity $1.13B, long-term debt $845M
• Sep 29, 2024: cash $25.4M, total assets $3.07B, total liabilities $1.86B, shareholders' equity $1.18B, long-term debt $805M

What is DNUT's revenue?

KRISPY KREME INC reported $1.47B of revenue over its last four quarters, through June 28, 2026.

Is DNUT profitable?

No. KRISPY KREME INC lost $98.3M over the last four quarters.

What is DNUT's EPS?

Diluted earnings per share over the last four quarters were −$0.55; −$0.12 in the latest quarter.

Does DNUT pay a dividend?

KRISPY KREME INC paid $0.04 per share in dividends in the fiscal year ended December 2025.

DNUT ownership and insider trades · All stocks